Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the ratL M Burrell, R Chan, P A Phillips, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1995
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonismL M Burrell, P A Phillips, J Risvanis, et al.
The American Journal of Physiology|August 5, 1998
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the ratL M Burrell, P A Phillips, J Risvanis, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the ratL M Burrell, P A Phillips, J M Stephenson, et al.
Journal of Receptor Research|January 1, 1989
[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptorsJ M Kelly, J M Abrahams, P A Phillips, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 1994
Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endothelin receptor blockade in vivo in cyclosporin hypertensionP A Phillips, K A Rolls, L M Burrell, et al.
Peptides|July 1, 1990
Vasopressin antisense peptide interactions with the V1 receptorJ M Kelly, D Trinder, P A Phillips, et al.
Pageof 16